相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Upregulation of PUM1 Expression in Preeclampsia Impairs Trophoblast Invasion by Negatively Regulating the Expression of the lncRNA HOTAIR
Yan Zhang et al.
MOLECULAR THERAPY (2020)
PDL1 blockage increases fetal resorption and Tfr cells but does not affect Tfh/Tfr ratio and B-cell maturation during allogeneic pregnancy
Weihong Zeng et al.
CELL DEATH & DISEASE (2020)
被撤回的出版物: Elevated Tristetraprolin Impairs Trophoblast Invasion in Women with Recurrent Miscarriage by Destabilization of HOTAIR (Retracted article. See vol. 28, pg. 599, 2022)
Fu-Ju Tian et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
Yu Pan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
Sheema Almozyan et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression
Stefan Kraft et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
Yunfei Liao et al.
ONCOTARGET (2017)
B7-H3 promotes gastric cancer cell migration and invasion
Yecheng Li et al.
ONCOTARGET (2017)
Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
Goodwin G. Jinesh et al.
SCIENTIFIC REPORTS (2017)
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
Lujun Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
Nan Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Riki Okita et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels
Amrita Salvi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth
Ricardo Gargini et al.
CELL REPORTS (2016)
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
Harshita B. Gupta et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Decreased Stathmin-1 Expression Inhibits Trophoblast Proliferation and Invasion and Is Associated with Recurrent Miscarriage
Fu-Ju Tian et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al.
CELL (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer
Xiao Song et al.
ONCOLOGY REPORTS (2014)
被撤回的出版物: Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis (Retracted article. See vol. 48, pg. 206, 2022)
Wei Dai et al.
ONCOLOGY REPORTS (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Signaling mechanisms of the epithelial-mesenchymal transition
David M. Gonzalez et al.
SCIENCE SIGNALING (2014)
Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer
Takayuki Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
Sofia Lyford-Pike et al.
CANCER RESEARCH (2013)
WIP Provides an Essential Link between Nck and N-WASP during Arp2/3-Dependent Actin Polymerization
Sara K. Donnelly et al.
CURRENT BIOLOGY (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
Elad Noy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Actin-bundling proteins in cancer progression at a glance
Richard P. Stevenson et al.
JOURNAL OF CELL SCIENCE (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans
Kun-Wei Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Chuan-Yong Mu et al.
MEDICAL ONCOLOGY (2011)
Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
Kosei Yasumoto et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2009)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Protein-tyrosine phosphatases and cancer
A Östman et al.
NATURE REVIEWS CANCER (2006)
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
RH Thompson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)